02-056-3333

Duangnate Rojanaporn, MD, FICO



Subspecialty

General Ophthalmology , Cataract , Retina Ocular Oncology

Education

1995 – 2001 Doctor of Medicine, Siriraj Hospital, Mahidol University
2007 – 2008  Vitreous Retina, Faculty of Medicine, Ramathibodi Hospital, Mahidol University

Residencies

2001 Internship, Faculty of Medicine, Srinagarind Hospital, Khonkaen University, Khonkaen, Thailand
2002 – 2004 Internship, Department of Ophthalmology, Faculty of Medicine Srinagarind Hospital, Khonkaen University, Khonkaen, Thailand
2004 – 2007 Resident, Department of Ophthalmology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
2007 Chief resident, Department of Ophthalmology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

Board Certification

2002 Certificate, Basic and Clinical Science in Medicine, Faculty of   Postgraduates, Khonkaen University, Khonkaen, Thailand
2004 Certificate, Basic and Clinical Science in Medicine, Faculty of  Postgraduates, Mahidol University, Bangkok, Thailand
2007 Diplomat, Thai Board of Ophthalmology, Department of Ophthalmology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
2018 – 2019 Certificate of Achievement of the Academic Development Mentorship Scheme (ADMS) of the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) with gold medal award
2019 – 2020 Certificate of Achievement of the Asia-Pacific Vitreoretinal society leadership program with silver medal award

Fellowships

2005 Passed International Council of Ophthalmology Assessments for Ophthalmologists Part 1 (Basic science)
2006 Passed International Council of Ophthalmology Assessments for Ophthalmologists Part 2 (Optics and refraction)
2007 Passed International Council of Ophthalmology Assessments for Ophthalmologists Part 3 (Clinical science) with Merit
2007 – 2008 Clinical Vitreoretinal Fellow, Department of Ophthalmology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
2008 – 2009 Fellowship in Medical & Surgical Retina, New York Eye & Ear Infirmary, New York, USA
2008 – 2009 International Retinal Fellow, Retina Unit, Departmentof Ophthalmology, New York Eye and Ear Infirmary, New York, USA (Funded by International Council of Ophthalmology
2009 Clinical observational fellow, Charles retina institute, Memphis, USA
2011 – 2012 Fellowship in Ocular Oncology Wills Eye Institute, Philadelphia, USA
2010 Passed advanced International Council of Ophthalmology Assessments for senior ophthalmologist
2011 – 2012 Research Fellow in Ocular Oncology, Wills Eye Institute, Philadelphia, USA
2010 – Present Course instructor: Retina service, Department of Ophthalmology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
2022 – Present Associate Professor in OphthalmologyDepartment of Ophthalmology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

Researches and Publications

Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids.
J Exp Clin Cancer Res. 2023 Feb 1;42(1):39. doi: 10.1186/s13046-023-02608-1.PMID: 36726110

The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries.
Lancet Glob Health. 2022 Aug;10(8):e1128-e1140. doi: 10.1016/S2214-109X(22)00250-9.PMID: 35839812

Sex, gender, and retinoblastoma: analysis of 4351 patients from 153 countries.
Eye (Lond). 2022 Aug;36(8):1571-1577. doi: 10.1038/s41433-021-01675-y. Epub 2021 Jul 16.PMID: 34272514

Germline RB1 Mutation in Retinoblastoma Patients: Detection Methods and Implication in Tumor Focality.
Transl Vis Sci Technol. 2022 Sep 1;11(9):30. doi: 10.1167/tvst.11.9.30.PMID: 36173648

Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report.
Am J Ophthalmol Case Rep. 2022 Dec;28:101707. doi: 10.1016/j.ajoc.2022.101707. Epub 2022 Sep 16.PMID: 36128343

Fatal Air Embolism after Choroidal Melanoma Endoresection without Air Infusion: A Case Report.
Ocul Oncol Pathol. 2021 Oct;7(5):321-325. doi: 10.1159/000518976. Epub 2021 Aug 13.PMID: 34722487

Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation.
Invest Ophthalmol Vis Sci. 2020 Dec 1;61(14):8. doi: 10.1167/iovs.61.14.8.PMID: 33270844

Clinical Presentations and Outcomes of Retinoblastoma Patients in relation to the Advent of New Multimodal Treatments: A 12-Year Report from Single Tertiary Referral Institute in Thailand.
J Ophthalmol. 2020 Sep 10;2020:4231841. doi: 10.1155/2020/4231841. eCollection 2020.PMID: 33005446  

Retinoblastoma: Etiology, Modeling, and Treatment.
Cancers (Basel). 2020 Aug 16;12(8):2304. doi: 10.3390/cancers12082304.PMID: 32824373  

Global Retinoblastoma Presentation and Analysis by National Income Level.
JAMA Oncol. 2020 May 1;6(5):685-695. doi: 10.1001/jamaoncol.2019.6716.PMID: 32105305

 Intra-Arterial Chemotherapy for Retinoblastoma: 8-Year Experience from a Tertiary Referral Institute in Thailand.
Asia Pac J Ophthalmol (Phila). 2019 May-Jun;8(3):211-217. doi: 10.22608/APO.2018294. Epub 2019 Feb 4.PMID: 30714357

Spectrum of germline RB1 mutations and clinical manifestations in retinoblastoma patients from Thailand.
Mol Vis. 2018 Dec 9;24:778-788. eCollection 2018.PMID: 30636860  

Novel mutation of the TINF2 gene resulting in severe phenotypic Revesz syndrome.
Pediatr Blood Cancer. 2019 Mar;66(3):e27557. doi: 10.1002/pbc.27557. Epub 2018 Nov 26.PMID: 30478948

Retinoblastoma in Asia. Eye (Lond).
2019 Jan;33(1):87-96. doi: 10.1038/s41433-018-0244-7. Epub 2018 Nov 1.PMID: 30385881  

A three-dimensional organoid model recapitulates tumorigenic aspects and drug responses of advanced human retinoblastoma.
Sci Rep. 2018 Oct 23;8(1):15664. doi: 10.1038/s41598-018-34037-y.PMID: 30353124  

Intravitreal anti-vascular endothelial growth factor injections for exudative retinal arterial macroaneurysms.
Retina. 2019 Jun;39(6):1133-1141. doi: 10.1097/IAE.0000000000002131.PMID: 29505440

Idiopathic polypoidal choroidal vasculopathy in Thai patients with clinical and angiographic choroidal neovascularization.
Clin Ophthalmol. 2017 Feb 9;11:317-322. doi: 10.2147/OPTH.S126226. eCollection 2017.PMID: 28223776

Epstein-Barr virus-associated iris smooth muscle tumor with epithelioid morphology in AIDS patients: a case report.
Int Med Case Rep J. 2016 Mar 30;9:83-6. doi: 10.2147/IMCRJ.S96837. eCollection 2016.PMID: 27099533  

Enhanced depth imaging optical coherence tomography of circumscribed choroidal hemangioma in 10 consecutive cases.
Middle East Afr J Ophthalmol. 2015 Apr-Jun;22(2):192-7. doi: 10.4103/0974-9233.150629.PMID: 25949077  

Monthly intravitreal bevacizumab for macular edema after iodine-125 plaque radiotherapy of uveal melanoma.
Eur J Ophthalmol. 2014 Mar-Apr;24(2):228-34. doi: 10.5301/ejo.5000352. Epub 2013 Aug 9.PMID: 23934823

Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
Retina. 2013 Nov-Dec;33(10):2103-9. doi: 10.1097/IAE.0b013e318295f783.PMID: 23873161

Retinal vasoproliferative tumors: comparative clinical features of primary vs secondary tumors in 334 cases.
JAMA Ophthalmol. 2013 Mar;131(3):328-34. doi: 10.1001/2013.jamaophthalmol.524.PMID: 23494037

High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes.
Ophthalmology. 2013 May;120(5):997-1003. doi: 10.1016/j.ophtha.2012.10.044. Epub 2013 Feb 8.PMID: 23399379

Scleral necrosis after plaque radiotherapy of uveal melanoma: a case-control study.
Ophthalmology. 2013 May;120(5):1004-11. doi: 10.1016/j.ophtha.2012.10.021. Epub 2013 Jan 21.PMID: 23347983

Morning glory disc anomaly with peripheral retinal nonperfusion in 4 consecutive cases.
Arch Ophthalmol. 2012 Oct;130(10):1327-30. doi: 10.1001/archophthalmol.2012.505.PMID: 23044951 

Orange pigment sediment overlying small choroidal melanoma.
Arch Ophthalmol. 2012 Jul;130(7):937-9. doi: 10.1001/archophthalmol.2011.1907.PMID: 22776939  

Enhanced depth imaging optical coherence tomography of small choroidal melanoma: comparison with choroidal nevus.
Arch Ophthalmol. 2012Jul;130(7):850-6. doi: 10.1001/archophthalmol.2012.1135.PMID: 22776921

Intravenous chemoreduction or intra-arterial chemotherapy for cavitary retinoblastoma: long-term results.
Arch Ophthalmol. 2012 May;130(5):585-90. doi: 10.1001/archophthalmol.2011.2825.PMID: 22652844

Intravenous and intra-arterial chemotherapy for retinoblastoma: what have we learned?
Curr Opin Ophthalmol. 2012 May;23(3):202-9. doi: 10.1097/ICU.0b013e3283524130.PMID: 22450222  

Prevalence of dry eye in Bangkok, Thailand. Cornea.
2006 Dec;25(10):1162-7. doi: 10.1097/01.ico.0000244875.92879.1a.PMID: 17172891